Immunohistochemical localization of advanced glycation end products in pinguecula

[1]  C. Murphy,et al.  Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro. , 2003, Optometry.

[2]  Kaori Suzuki,et al.  Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. , 2003, Investigative ophthalmology & visual science.

[3]  J. V. van Best,et al.  Corneal autofluorescence in relation to permeability of the blood-aqueous barrier in diabetic patients with clinically significant macular edema and in an age-matched control group , 2003, Current eye research.

[4]  S. Horiuchi,et al.  Accumulation of imidazolone, pentosidine and Nɛ‐(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain , 2002, Pathology international.

[5]  J. Dawczynski,et al.  Advanced glycation end-products in corneas of patients with keratoconus , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  M. Kasper,et al.  Age-related changes in cells and tissues due to advanced glycation end products (AGEs). , 2001, Archives of gerontology and geriatrics.

[7]  Alan W. Stitt,et al.  Advanced glycation: an important pathological event in diabetic and age related ocular disease , 2001, The British journal of ophthalmology.

[8]  A. Yoshida,et al.  Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. , 2001, Diabetes care.

[9]  T. Oshika,et al.  Advanced glycation end products in human optic nerve head , 2001, The British journal of ophthalmology.

[10]  M. Araie,et al.  Advanced glycation end products in diabetic corneas. , 2000, Investigative ophthalmology & visual science.

[11]  M. Jadoul,et al.  Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. , 1998, Journal of the American Society of Nephrology : JASN.

[12]  S. Horiuchi,et al.  Advanced glycation end products in age-related macular degeneration. , 1998, Archives of ophthalmology.

[13]  J. Mott,et al.  Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. , 1997, Kidney international.

[14]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Morino,et al.  Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. , 1992, The Journal of biological chemistry.

[16]  Y. Morino,et al.  Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. , 1991, The Journal of biological chemistry.

[17]  B. Streeten,et al.  Elastic fiber components and protease inhibitors in pinguecula. , 1991, Investigative ophthalmology & visual science.

[18]  V. Monnier,et al.  Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo. , 1989, The Journal of biological chemistry.

[19]  E. Perkins.  The association between pinguecula, sunlight and cataract. , 1985, Ophthalmic research.

[20]  J. Young,et al.  Primary spheroidal degeneration of the cornea in Labrador and northern Newfoundland. , 1975, American journal of ophthalmology.